Make an Appointment
-
Palo Alto Medical Foundation795 El Camino Real, Palo Alto, CA 94301 map
Dr. Christine Ching is an oncologist in Palo Alto. She provides diagnostic and treatment services for patients suffering from all types of cancer.
Palo Alto Medical Foundation
Accepting New Patients?
Yes, Dr. Christine D. Ching is accepting new patients at this office.
Phone
Address
795 El Camino Real, Palo Alto, CA 94301
Office Details
Insurance Accepted
- Medicare
Bio
Dr. Christine Ching graduated from Duke University School of Medicine in 2000.
Dr. Ching has one office in California where she specializes in Oncology and Hematology / Oncology.
Dr. Ching works with one doctor, Dr. Runi Chattopadhyay.
Specialties
-
Oncology
As an oncologist, Dr. Ching is trained to diagnose and treat all types and forms of cancer. Dr. Ching may employ a variety of diagnostic tests such as biopsies, imaging tests, endoscopic tests and laboratory tests. She may offer treatment techniques such as chemotherapy or radiotherapy to combat the spread of cancer. Dr. Ching may also provide emotional and palliative care, ensuring patients experience the highest quality of life possible.
-
Hematology / Oncology
As a hematologist / oncologist in California, Dr. Ching is capable of diagnosing and treating patients with blood-related disorders, malignancies, or cancers. Dr. Ching may treat a range of conditions ranging from the the common to the very rare and complex. As a result, Dr. Ching may provide care as part of a multidisciplinary team, working in conjunction with other specialists to ensure the highest possible standard of care.
Education & Training
Hospital Affiliations
- Mills Peninsula Hospital
- Stanford Health Care
Languages Spoken
- English
Links & Social Media
Latest Oncology News
-
Catnip: The 'Why' Behind Cats' Favorite HighRobert Preidt, Dec 10, 2018 at 12:00 PM
-
Incontinence Drug May Cut Hot Flashes in Breast Cancer SurvivorsSteven Reinberg, HealthDay Reporter, Dec 7, 2018 at 9:00 AM
-
Healthy Lifestyle Lowers Odds of Breast Cancer's ReturnRobert Preidt, Dec 7, 2018 at 9:00 AM